Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03894215
Title Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Agenus Inc.

cervical adenosquamous carcinoma

cervical squamous cell carcinoma

cervical adenocarcinoma



Balstilimab + Zalifrelimab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.